The principle of momentum investing—though contrary to the traditional wisdom of buying low and selling high—suggests that investors can profit by buying rising stocks and selling them before they decline. As a result, momentum is typically favored in short-term and active trading stra.... |
Good MorningEquity markets started the week on weakened footing following the start of Trump's tariffs. However, the news isn't all bad. Investors bought the early morning weakness, leaving the S&P 500 well off the session's lows by the day's end. The takeaway is that Trump's tariffs will likely cause market volatility, but the upward trend is intact, and new all-time-high index prices are possible.
Earnings will help drive the action this week. After the Monday close, an after-hours report from Palantir underscored the impact of AI on business, leading its stock to a 15% gain. Other critical reports include Advanced Micro Devices, Amazon, and Google, all expected to report solidly.
Critical economic data is also expected this week. Monthly labor data are due, including the ADP, Challenger, JOLTs, and non-farm payroll reports. The consensus is that the data align with trends, including steady job creation, low unemployment, and rising wages. Featured: Elon’s big $266,000 per second purchase (Ad) 
| Medical | |
The principle of momentum investing—though contrary to the traditional wisdom of buying low and selling high—suggests that investors can profit by buying rising stocks and selling them before they decline. As a result, momentum is typically favored in short-term and active trading stra... Read the Full Story |
| From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
| Markets | |
Starting small is usually good advice when beginning a new endeavor. If you’re trying to get back in shape, a quick run or light workout is a better starting point than a marathon. However, that logic is counterintuitive when it comes to stocks. Bigger stocks tend to be safer and less volati... Read the Full Story |
| Industrials | |
Insider buying was solid in January, including dividend-paying names like Lakeland Industries (NASDAQ: LAKE), York Water (NASDAQ: YORW), and RLI Corp (NYSE: RLI). These stocks are not only the most bought dividend stocks insiders bought but the most bought for the month, news that raises the quest... Read the Full Story |
| From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
| Retail/Wholesale | |
The Wall Street Journal pointed out a peculiar new trend on social media, where influencers are not showcasing their lavish purchases but rather going the opposite route, embracing a “No Buy” trend. Consumers are tired of inflation and lofty credit card interest rates and have deemed 2... Read the Full Story |
| Medical | |
Teva Pharmaceuticals Industries Ltd (NYSE: TEVA) is the world's largest generic drug maker, with over 500 generic and biosimilar treatments in its broad portfolio. The medical sector giant also has a line of branded drugs driving growth.
Its specialty medicines address specific conditions, incl... Read the Full Story |
| From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
| Finance | |
Three S&P 500 Index constituents, as well as one of the world’s biggest names in oil and gas, are raising dividends as 2025 gets started. The firm not in the S&P 500 also announced billions in new buyback authorization. All dividend yield and return metrics use prices as of the Jan. ... Read the Full Story |
| Consumer Staples | |
Global consumer products manufacturer Proctor & Gamble Co. (NYSE: PG) posted upbeat earnings in its fourth quarter of 2024.
The consumer staples sector leader sells well-known grooming, baby, personal care, and hygiene products under brands like Pampers, Luvs, Bounce, Downy, Gain, Tide, Bo... Read the Full Story |
| Markets | |
One of the top-performing sectors YTD has been financials, with the popular financial ETF, Financial Select Sector SPDR (NYSEARCA: XLF), already up 6.5% as of Friday’s close. Conversely, one of the sectors that outperformed for the first three quarters of last year, utilities, represented by... Read the Full Story |
| Consumer Staples | |
The 2024 holiday shopping season was a robust one. However, January has been nicknamed 'Returnuary' after the age-old tradition of returning products to retailers every year. The National Retail Federation (NRF) estimates a 17% return rate for all U.S. merchandise this year, which is equal to $890... Read the Full Story |
| Business Services | |
With a market capitalization of $265 million, Palladyne AI Corp. (NASDAQ: PDYN) remains a small software firm. However, its massive growth in the last year has provided it momentum far outpacing some of the trendiest larger companies—NVIDIA Corp.'s (NASDAQ: NVDA) 103% return in the year le... Read the Full Story |
| Tuesday's Early Bird Stock Of The Day CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island. | Should I Buy CVS Health Stock? CVS Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of CVS Health was last updated on Monday, July 13, 2026 at 6:22 PM.
CVS Health Bull Case -
The current stock price is around $102.84, reflecting a positive outlook from analysts who have rated the stock with a consensus of "Moderate Buy."
-
CVS Health Co. reported a significant increase in quarterly revenue, surpassing expectations, which indicates strong operational performance and growth potential.
-
The company has set ambitious earnings per share (EPS) guidance for FY 2026, suggesting confidence in future profitability and growth.
-
With a return on equity of 11.88%, CVS Health Co. demonstrates effective management of shareholder equity, which is a positive indicator for investors.
-
Analysts have recently raised their target prices for CVS Health Co., indicating a bullish sentiment and potential for stock appreciation.
CVS Health Bear Case -
The company has a relatively high P/E ratio of 46.18, which may suggest that the stock is overvalued compared to its earnings, potentially limiting future price appreciation.
-
CVS Health Co. has a net margin of only 0.72%, indicating that profitability may be constrained, which could affect long-term growth prospects.
-
The quick ratio of 0.66 suggests that the company may face challenges in meeting short-term liabilities, which could raise concerns about liquidity.
-
Despite recent revenue growth, the company operates in a highly competitive healthcare market, which could impact its ability to maintain market share and profitability.
-
The debt-to-equity ratio of 0.78 indicates that CVS Health Co. has a moderate level of debt, which could pose risks if interest rates rise or if the company faces financial difficulties.
| | View Today's Stock Pick |
|
| |
|
|
